143 related articles for article (PubMed ID: 37925056)
21. Learning a Cytometric Deep Phenotype Embedding for Automatic Hematological Malignancies Classification.
Li JL; Wang YF; Ko BS; Li CC; Tang JL; Lee CC
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1733-1736. PubMed ID: 31946232
[TBL] [Abstract][Full Text] [Related]
22. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
Du Pisani LA; Shires K
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
[TBL] [Abstract][Full Text] [Related]
23. Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
Reiter M; Diem M; Schumich A; Maurer-Granofszky M; Karawajew L; Rossi JG; Ratei R; Groeneveld-Krentz S; Sajaroff EO; Suhendra S; Kampel M; Dworzak MN;
Cytometry A; 2019 Sep; 95(9):966-975. PubMed ID: 31282025
[TBL] [Abstract][Full Text] [Related]
24. Label-free cell detection of acute leukemia using ghost cytometry.
Kawamura Y; Nakanishi K; Murata Y; Teranishi K; Miyazaki R; Toda K; Imai T; Kajiwara Y; Nakagawa K; Matsuo H; Adachi S; Ota S; Hiramatsu H
Cytometry A; 2024 Mar; 105(3):196-202. PubMed ID: 38087915
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
[TBL] [Abstract][Full Text] [Related]
26. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears.
Eckardt JN; Schmittmann T; Riechert S; Kramer M; Sulaiman AS; Sockel K; Kroschinsky F; Schetelig J; Wagenführ L; Schuler U; Platzbecker U; Thiede C; Stölzel F; Röllig C; Bornhäuser M; Wendt K; Middeke JM
BMC Cancer; 2022 Feb; 22(1):201. PubMed ID: 35193533
[TBL] [Abstract][Full Text] [Related]
27. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
Wongprajun S; Auewarakul CU
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
[TBL] [Abstract][Full Text] [Related]
28. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
[TBL] [Abstract][Full Text] [Related]
29. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
[TBL] [Abstract][Full Text] [Related]
30. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.
Terwijn M; van Putten WL; Kelder A; van der Velden VH; Brooimans RA; Pabst T; Maertens J; Boeckx N; de Greef GE; Valk PJ; Preijers FW; Huijgens PC; Dräger AM; Schanz U; Jongen-Lavrecic M; Biemond BJ; Passweg JR; van Gelder M; Wijermans P; Graux C; Bargetzi M; Legdeur MC; Kuball J; de Weerdt O; Chalandon Y; Hess U; Verdonck LF; Gratama JW; Oussoren YJ; Scholten WJ; Slomp J; Snel AN; Vekemans MC; Löwenberg B; Ossenkoppele GJ; Schuurhuis GJ
J Clin Oncol; 2013 Nov; 31(31):3889-97. PubMed ID: 24062400
[TBL] [Abstract][Full Text] [Related]
31. Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data.
Rajwa B; Wallace PK; Griffiths EA; Dundar M
IEEE Trans Biomed Eng; 2017 May; 64(5):1089-1098. PubMed ID: 27416585
[TBL] [Abstract][Full Text] [Related]
32. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
Fang H; Wang SA; Hu S; Konoplev SN; Mo H; Liu W; Zuo Z; Xu J; Jorgensen JL; Yin CC; El Hussein S; Jelloul FZ; Tang Z; Medeiros LJ; Wang W
Cytometry B Clin Cytom; 2022 Jul; 102(4):283-291. PubMed ID: 35716019
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
[TBL] [Abstract][Full Text] [Related]
34. Analysis of flow cytometry data by matrix relevance learning vector quantization.
Biehl M; Bunte K; Schneider P
PLoS One; 2013; 8(3):e59401. PubMed ID: 23527184
[TBL] [Abstract][Full Text] [Related]
35. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X; Cherian S
Clin Lab Med; 2017 Dec; 37(4):753-769. PubMed ID: 29128067
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometry in detection of Nucleophosmin 1 mutation in acute myeloid leukemia patients: A reproducible tertiary hospital experience.
El-Gamal RAE; Hashem AE; Habashy DM; Abou Elwafa MAZ; Boshnak NH
Int J Lab Hematol; 2021 Feb; 43(1):68-75. PubMed ID: 32856429
[TBL] [Abstract][Full Text] [Related]
39. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]